{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:41:46Z","timestamp":1777657306973,"version":"3.51.4"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Undergraduate Training Program for Innovation and Entrepreneurship","award":["202010367035"],"award-info":[{"award-number":["202010367035"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To explore the influencing factors of prostate cancer occurrence, set up risk prediction model, require reference for the preliminary diagnosis of clinical doctors, this model searched database through the data of prostate cancer patients and prostate hyperplasia patients National Clinical Medical Science Data Center.<\/jats:p>\n            <jats:p>With the help of Stata SE 12.0 and SPSS 25.0 software, the biases between groups were balanced by propensity score matching. Based on the matched data, the relevant factors were further screened by stepwise logistic regression analysis, the key variable and artificial neural network model are established. The prediction accuracy of the model is evaluated by combining the probability of test set with the area under receiver operating characteristic curve (ROC).<\/jats:p>\n            <jats:p>After 1:2 PSM, 339 pairs were matched successfully. There are 159 cases in testing groups and 407 cases in training groups. And the regression model was <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a1\u200a\/ (1 + e (0.122 \u2217 age + 0.083 \u2217 Apo lipoprotein C3 + 0.371 \u2217 total prostate specific antigen (tPSA) \u22120.227 \u2217 Apo lipoprotein C2\u20136.093 \u2217 free calcium (iCa) + 0.428 \u2217 Apo lipoprotein E-1.246 \u2217 triglyceride-1.919 \u2217 HDL cholesterol + 0.083 \u2217 creatine kinase isoenzyme [CKMB])). The logistic regression model performed very well (ROC, 0.963; 95% confidence interval, 0.951 to 0.978) and artificial neural network model (ROC, 0.983; 95% confidence interval, 0.964 to 0.997). High degree of Apo lipoprotein E (Apo E) (Odds Ratio, [OR], 1.535) in blood test is a risk factor and high triglyceride (TG) (OR, 0.288) is a protective factor.<\/jats:p>\n            <jats:p>It takes the biochemical examination of the case as variables to establish a risk prediction model, which can initially reflect the risk of prostate cancer and bring some references for diagnosis and treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025602","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T03:00:32Z","timestamp":1619578832000},"page":"e25602","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Based on biomedical index data"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8004-7965","authenticated-orcid":false,"given":"Hanxu","family":"Guo","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Bengbu Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjie","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Bengbu Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Bengbu Medical College, Anhui Biochemical Drug Engineering Technology Research Center, Bengbu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"R1-20250524","first-page":"07","article-title":"Cancer statistics, 2019","volume":"69","author":"RL","year":"2019","journal-title":"CA"},{"key":"R2-20250524","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.1995.03520310046028","article-title":"The role of increasing detection in the rising incidence of prostate cancer","volume":"273","author":"AL","year":"1995","journal-title":"JAMA"},{"key":"R3-20250524","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US preventive services task force recommendation statement","volume":"319","author":"DC","year":"2018","journal-title":"JAMA"},{"key":"R4-20250524","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.eururo.2020.02.009","article-title":"Radical prostatectomy or observation for clinically localized prostate cancer: extended follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)","volume":"77","author":"Wilt","year":"2020","journal-title":"Eur Urol"},{"key":"R5-20250524","doi-asserted-by":"crossref","first-page":"540","DOI":"10.5694\/mja12.11241","article-title":"Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011","volume":"198","author":"Evans","year":"2013","journal-title":"Med J Australia"},{"key":"R6-20250524","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.6004\/jnccn.2015.0182","article-title":"PSA screening for prostate cancer: why saying No is a high-value health care choice","volume":"13","author":"Wilt","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"R7-20250524","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/aja.2012.28","article-title":"External validation of the prostate cancer prevention trial and the European randomized study of screening for prostate cancer risk calculators in a Chinese cohort","volume":"14","author":"Y","year":"2012","journal-title":"Asian J Androl"},{"key":"R8-20250524","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4103\/1008-682X.177840","article-title":"Detecting prostate cancer and prostatic calcifications using advanced magnetic resonance imaging","volume":"19","author":"S","year":"2017","journal-title":"Asian J Androl"},{"key":"R9-20250524","first-page":"1378","article-title":"A novel fluorescent probe for the early detection of prostate cancer based on endogenous zinc sensing","volume":"79","author":"S","year":"2019","journal-title":"Prostate"},{"key":"R10-20250524","first-page":"343","article-title":"Peduzzi PJTYjob, medicine","volume":"86","author":"Dziura","year":"2013","journal-title":"Strategies for dealing with missing data in clinical trials: from design to analysis"},{"key":"R11-20250524","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/1471-0528.12219","article-title":"Proper analysis in clinical trials: how to report and adjust for missing outcome data","volume":"120","author":"Joshi","year":"2013","journal-title":"BJOG"},{"key":"R12-20250524","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/1475-6773.12182","article-title":"Methods for constructing and assessing propensity scores","volume":"49","author":"Garrido","year":"2014","journal-title":"Health Serv Res"},{"key":"R13-20250524","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ejcts\/ezy167","article-title":"Statistical primer: propensity score matching and its alternatives","volume":"53","author":"Benedetto","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"R14-20250524","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/cam4.695","article-title":"Blood lipids and prostate cancer: a Mendelian randomization analysis","volume":"5","author":"Bull","year":"2016","journal-title":"Cancer Med"},{"key":"R15-20250524","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/pros.10343","article-title":"Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer","volume":"58","author":"Hall","year":"2004","journal-title":"Prostate"},{"key":"R16-20250524","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12916-017-0976-4","article-title":"Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort","volume":"15","author":"Katzke","year":"2017","journal-title":"BMC Med"},{"key":"R17-20250524","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.mcna.2020.08.007","article-title":"Screening for prostate cancer","volume":"104","author":"Carlsson","year":"2020","journal-title":"Med Clin North Am"},{"key":"R18-20250524","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3945\/ajcn.114.088716","article-title":"Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up study","volume":"101","author":"Wilson","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"R19-20250524","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/ijms19041237","article-title":"Calcium and nuclear signaling in prostate cancer","volume":"19","author":"Maly","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R20-20250524","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/ajcn\/nqy037","article-title":"Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP)","volume":"107","author":"Steck","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"R21-20250524","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0731-7085(99)00272-1","article-title":"Analysis b Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research","volume":"22","author":"Agatonovic-Kustrin","year":"2000","journal-title":"J Pharm Biomed Anal"},{"key":"R22-20250524","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/1097-0045(200101)46:1<39::AID-PROS1006>3.0.CO;2-M","article-title":"Introduction to artificial neural networks for physicians: taking the lid off the black box","volume":"46","author":"Rodvold","year":"2001","journal-title":"Prostate"},{"key":"R23-20250524","doi-asserted-by":"crossref","first-page":"49","DOI":"10.23736\/S0393-2249.19.03613-0","article-title":"Artificial intelligence and neural networks in urology: current clinical applications","volume":"72","author":"Checcucci","year":"2020","journal-title":"Minerva Urol Nefrol"},{"key":"R24-20250524","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2008.05.022","article-title":"The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review","volume":"54","author":"Schr\u00f6der","year":"2008","journal-title":"Eur Urol"},{"key":"R25-20250524","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1200\/JCO.2007.12.2721","article-title":"Predicting outcomes in prostate cancer: how many more nomograms do we need?","volume":"25","author":"Ross","year":"2007","journal-title":"J Clin Oncol"},{"key":"R26-20250524","first-page":"848","article-title":"Do prostate cancer risk models improve the predictive accuracy of PSA screening?","volume":"26","author":"Louie","year":"2015","journal-title":"A meta-analysis"},{"key":"R27-20250524","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.294.1.66","article-title":"Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3 0\u200ang\/ml or lower","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"R28-20250524","first-page":"228","article-title":"The risk factors of prostate cancer and its prevention: a literature review","volume":"48","author":"NR","year":"2016","journal-title":"Acta medica Indonesiana"},{"key":"R29-20250524","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1515\/cclm-2019-0693","article-title":"Biomarkers for prostate cancer: prostate-specific antigen and beyond","volume":"58","author":"MJ","year":"2020","journal-title":"Clin Chem Laboratory Med"},{"key":"R30-20250524","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1158\/1055-9965.EPI-15-0367","article-title":"No association of ApoE genotype with risk of prostate cancer: a nested case-control study","volume":"24","author":"H","year":"2015","journal-title":"Cancer Epidemiol, Biomarkers Prevention"},{"key":"R31-20250524","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3892\/ijo.2013.2057","article-title":"Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis","volume":"43","author":"GO","year":"2013","journal-title":"Int J Oncol"},{"key":"R32-20250524","first-page":"707","article-title":"Apolipoprotein E genotypes in patients with prostate cancer","volume":"36","author":"F","year":"2016","journal-title":"Anticancer Research"},{"key":"R33-20250524","doi-asserted-by":"crossref","first-page":"e13321","DOI":"10.1111\/and.13321","article-title":"Oxidised low-density lipoprotein, a possible distinguishing lipid profile biomolecule between prostate cancer and benign prostatic hyperplasia","volume":"51","author":"Asare","year":"2019","journal-title":"Andrologia"},{"key":"R34-20250524","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1158\/1055-9965.EPI-14-0458","article-title":"Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database","volume":"23","author":"EH","year":"2014","journal-title":"Cancer Epidemiol, Biomarkers Prevention"},{"key":"R35-20250524","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s10552-008-9197-7","article-title":"Hypercholesterolemia and prostate cancer: a hospital-based case-control study","volume":"19","author":"L","year":"2008","journal-title":"Cancer Causes Control"},{"key":"R36-20250524","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pros.2990150105","article-title":"Intracellular distribution of calcium and zinc in normal, hyperplastic, and neoplastic human prostate: X-ray microanalysis of freeze-dried cryosections","volume":"15","author":"KE","year":"1989","journal-title":"Prostate"},{"key":"R37-20250524","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000330095","article-title":"S100A8 and S100A9: new insights into their roles in malignancy","volume":"4","author":"G","year":"2012","journal-title":"J Innate Immunity"},{"key":"R38-20250524","doi-asserted-by":"crossref","first-page":"8476","DOI":"10.1038\/s41598-017-09158-5","article-title":"Myosin is oform expressed in metastatic prostate cancer stimulates cell invasion","volume":"7","author":"Maly","year":"2017","journal-title":"Sci Rep"},{"key":"R39-20250524","first-page":"580","article-title":"False increased CK-MB value after cryoablation of the prostate without myocardial infarct","volume":"32","author":"A","year":"1997","journal-title":"Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie"},{"key":"R40-20250524","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2004.08.047","article-title":"Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker","volume":"96","author":"HG","year":"2005","journal-title":"Gynecologic Oncol"},{"key":"R41-20250524","first-page":"272","article-title":"Macro creatine kinase: illness marker. Practical guide for the management","volume":"23","author":"M","year":"2006","journal-title":"Anales de Medicina Interna"},{"key":"R42-20250524","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.7314\/APJCP.2015.16.15.6599","article-title":"Creatine Kinase (CK)-MB-to-Total-CK Ratio: a Laboratory Indicator for Primary Cancer Screening","volume":"16","author":"CC","year":"2015","journal-title":"Asian Pacific J Cancer Prevention"},{"key":"R43-20250524","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1476-4598-13-250","article-title":"MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1","volume":"13","author":"Rajendiran","year":"2014","journal-title":"Mol Cancer"},{"key":"R44-20250524","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.1038\/s41598-017-11351-5","article-title":"MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"R45-20250524","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/aid.2018.0198","article-title":"Raman-enhanced spectroscopy distinguishes anal squamous intraepithelial lesions in human immunodeficiency virus-serodiscordant couples","volume":"35","author":"Oda","year":"2019","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R46-20250524","doi-asserted-by":"crossref","first-page":"04","DOI":"10.1038\/s41391-017-0007-8","article-title":"The use of PET\/CT in prostate cancer","volume":"21","author":"Li","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R47-20250524","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1053-4296(98)80044-1","article-title":"Evaluating tumor biology and oncological disease with positron-emission tomography","volume":"8","author":"Silverman","year":"1998","journal-title":"Semin Radiat Oncol"},{"key":"R48-20250524","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eururo.2016.01.029","article-title":"New clinical indications for (18) F\/(11)C-choline new tracers for positron emission tomography and a promising hybrid device for prostate cancer staging: a systematic review of the literature","volume":"70","author":"Evangelista","year":"2016","journal-title":"Eur Urol"},{"key":"R49-20250524","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1593\/neo.122146","article-title":"Epigenomic alterations in localized and advanced prostate cancer","volume":"15","author":"Lin","year":"2013","journal-title":"Neoplasia"},{"key":"R50-20250524","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjmed.2019.08.055","article-title":"Propensity score matching: the \u2019Devil is in the details where more may be hidden than you know","volume":"133","author":"Reiffel","year":"2020","journal-title":"Am J Med"},{"key":"R51-20250524","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1002\/jcp.30229","article-title":"LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway","volume":"236","author":"Jung","year":"2021","journal-title":"J Cell Physiol"},{"key":"R52-20250524","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.ackd.2016.11.010","article-title":"Observational research using propensity scores","volume":"23","author":"Raghunathan","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"R53-20250524","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4103\/1008-682X.181192","article-title":"The Huashan risk calculators performed better in prediction of prostate cancer in Chinese population: a training study followed by a validation study","volume":"18","author":"YS","year":"2016","journal-title":"Asian J Androl"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T17:08:38Z","timestamp":1748106518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025602"}},"subtitle":["Risk prediction model for prostate cancer"],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":53,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025602","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"assertion":[{"value":"2020-08-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}